{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T18:40:09Z","timestamp":1714502409769},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,24]],"date-time":"2012-10-24T00:00:00Z","timestamp":1351036800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>In a recent study we showed that in patients with primary biliary cirrhosis (PBC) being positive or negative for anti-M2 antibodies reacting with the 2-oxoacid-dehydrogenase complex (ODC) also antibodies to the beta- and gamma-subunits of F<jats:sub>1<\/jats:sub>F<jats:sub>0<\/jats:sub>-ATPase (anti-\u03b2, anti-\u03b3) occur. This is a mitochondrial enzyme but parts are also expressed on plasma membranes of endothelial cells. Here we wanted to analyse in more detail their clinical relevance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Fifty-nine untreated and histologically defined PBC patients who had been followed for at least five years were included into the study (51 anti-M2 positive, 8 anti-M2 negative). Twenty-three of them were treated in the follow up with ursodeoxycholic acid (UDCA), eight received during a trial methotrexate (MTX). In 13 patients orthotopic liver transplantation (OLT) had to be performed. Serum samples before and during therapy were available. Patients were analysed with respect to laboratory parameters, disease activity and histological stages.<\/jats:p><jats:p>Patients\u2019 sera were tested by ELISA for IgG- and IgM-antibodies against the beta- and gamma-subunits which had been recombinant expressed in<jats:italic>E.coli<\/jats:italic>and highly purified by electro-elution from SDS-gels after electrophoresis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Fifty-nine percent of the anti-M2 positive and 50% of the anti-M2 negative PBC patients had anti-\u03b2- and\/or anti-\u03b3-antibodies. There were no differences between anti-\u03b2- and\/or anti-\u03b3-antibody positive or negative patients with respect to biochemical parameters, immunoglobulins, histological stages or disease activity. Antibody reactivity significantly decreased during UDCA and MTX-treatment and also after OLT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Antibodies to the \u03b2- and \u03b3-subunits of F<jats:sub>1<\/jats:sub>F<jats:sub>0<\/jats:sub>-ATPase occur in anti-M2 positive and \u2013negative PBC but do not have any relevance with respect to clinical activity or prognosis. However, in contrast to the anti-M2 antibodies they decrease during UDCA and immunosuppressive therapy.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1471-230x-12-152","type":"journal-article","created":{"date-parts":[[2012,10,24]],"date-time":"2012-10-24T16:15:55Z","timestamp":1351095355000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Analysis of the clinical relevance of antimitochondrial antibodies to the \u03b2- and \u03b3-subunits of the F1F0-ATPase in patients with primary biliary cirrhosis"],"prefix":"10.1186","volume":"12","author":[{"given":"Dominik","family":"Nann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph P","family":"Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beate E","family":"Preu\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhild","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,24]]},"reference":[{"key":"823_CR1","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/S0140-6736(82)91327-7","volume":"II","author":"PA Berg","year":"1982","unstructured":"Berg PA, Klein R, Lindenborn-Fotinos J, Kl\u00f6ppel G: ATPase-associated antigen (M2): Marker antigen for serological diagnosis of primary biliary cirrhosis. Lancet. 1982, II: 1423-1425.","journal-title":"Lancet"},{"key":"823_CR2","first-page":"85","volume":"12","author":"PA Berg","year":"1990","unstructured":"Berg PA, Klein R: Autoantibodies in primary biliary cirrhosis. Sem Immunopathol. 1990, 12: 85-99.","journal-title":"Sem Immunopathol"},{"key":"823_CR3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/hep.1840080146","volume":"8","author":"PA Berg","year":"1988","unstructured":"Berg PA, Klein R: Molecular determination of the primary biliary cirrhosis-specific M2 antigen. Hepatol. 1988, 8: 200-201. 10.1002\/hep.1840080146.","journal-title":"Hepatol"},{"key":"823_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1042\/cs0770365","volume":"77","author":"SPM Fussey","year":"1989","unstructured":"Fussey SPM, Bassendine MF, Fittes D, Turner IB, James OFW, Yeaman SJ: The E1a and b subunits of the pyruvate dehydrogenase complex are M2'd' and M2'e' autoantigens in primary biliary cirrhosis. Clin Sci. 1989, 77: 365-368.","journal-title":"Clin Sci"},{"key":"823_CR5","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.4049\/jimmunol.138.10.3525","volume":"138","author":"ME Gershwin","year":"1987","unstructured":"Gershwin ME, Mackay IR, Sturgess A, Coppel AL: Identification and specificity of a cDNA encoding the 70kD mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol. 1987, 138: 3525-3531.","journal-title":"J Immunol"},{"key":"823_CR6","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/hep.1840050510","volume":"5","author":"J Lindenborn-Fotinos","year":"1985","unstructured":"Lindenborn-Fotinos J, Baum H, Berg PA: Mitochondrial antibodies in primary biliary cirrhosis: further characterization of the M2 antigen by immunoblotting revealing species and non-species specific determinants. Hepatol. 1985, 5: 763-769. 10.1002\/hep.1840050510.","journal-title":"Hepatol"},{"key":"823_CR7","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/S0140-6736(88)91894-6","volume":"I","author":"SJ Yeaman","year":"1988","unstructured":"Yeaman SJ, Danner DJ, Mutimer DJ, Fussey SPM, James OFW, Bassendine MF: Primary biliary cirrhosis: Identification of two major M2 mitochondrial autoantigens. Lancet. 1988, I: 1067-1070.","journal-title":"Lancet"},{"key":"823_CR8","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1373\/clinchem.2008.118299","volume":"55","author":"C D\u00e4hnrich","year":"2009","unstructured":"D\u00e4hnrich C, Pares A, Caballeria L, Rosemann A, Schlumberger W, Probst C, Mytilinaiou M, Bogdanos D, Vergani D, St\u00f6cker W, et al: New ELISA for detecting primary biliary cirrhosis-specific antimitochodnrial antibodies. Clin Chem. 2009, 55: 978-985. 10.1373\/clinchem.2008.118299.","journal-title":"Clin Chem"},{"key":"823_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/hep.510240117","volume":"24","author":"S Moteki","year":"1996","unstructured":"Moteki S, Leung PS, Coppel RL, Dickson ER, Kaplan MM, Munoz S, Gershwin ME: Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. Hepatol. 1996, 24: 97-103. 10.1002\/hep.510240117.","journal-title":"Hepatol"},{"key":"823_CR10","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s12016-010-8234-y","volume":"42","author":"N Bizzaro","year":"2012","unstructured":"Bizzaro N, Covini G, Rosina F, Muratori P, Tonutti E, Villalta D, Pesente F, Alessio MG, Tampoia M, Antico A, et al: Overcoming a \"probable\" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature. Cliln Rev Allergy Immunol. 2012, 42: 288-297. 10.1007\/s12016-010-8234-y.","journal-title":"Cliln Rev Allergy Immunol"},{"key":"823_CR11","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1136\/gut.2008.164335","volume":"58","author":"M Feuchtinger","year":"2009","unstructured":"Feuchtinger M, Christ S, Preu\u00df B, Dengjel J, Duman S, Stevanovic S, Klein R: Detection of novel non-M2-related antimitochondrial antibodies in patients with anti-M2 negative primary biliary cirrhosis. GUT. 2009, 58: 983-989. 10.1136\/gut.2008.164335.","journal-title":"GUT"},{"key":"823_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1478-3231.2011.02630.x","volume":"32","author":"B Preu\u00df","year":"2012","unstructured":"Preu\u00df B, Berg C, Dengjel J, Stevanovic S, Klein R: Relevance of the inner mitochondrial membrane enzyme F1F0-ATPase as an autoantigen in autoimmune liver disorders. Liver Int. 2012, 32: 249-257. 10.1111\/j.1478-3231.2011.02630.x.","journal-title":"Liver Int"},{"key":"823_CR13","volume-title":"WHO Handbook of Immunological Techniques","author":"IR Mackay","year":"1979","unstructured":"Mackay IR, Ritts RE: WHO Handbook of Immunological Techniques. 1979, Geneva"},{"key":"823_CR14","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1042\/bj1480533","volume":"148","author":"RB Beechey","year":"1974","unstructured":"Beechey RB, Hubbard SA, Linnett PE, Mitchel AD, Munn BA: A simple and rapid method for the preparation of adenosine triphosphatase from submitochondrial particles. Biochem J. 1974, 148: 533-537.","journal-title":"Biochem J"},{"key":"823_CR15","first-page":"267","volume":"50","author":"J Lindenborn-Fotinos","year":"1982","unstructured":"Lindenborn-Fotinos J, Sayers TJ, Berg PA: Mitochondrial antibodies in primary biliary cirrhosis. VI. Association of the complement fixing antigen with a component of the mitochondrial F1-ATPase complex. Clin Exp Immunol. 1982, 50: 267-","journal-title":"Clin Exp Immunol"},{"key":"823_CR16","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/hep.1840140632","volume":"14","author":"R Klein","year":"1991","unstructured":"Klein R, Eisenburg J, Weber P, Seibold F, Berg PA: Significance and specificity of antibodies to neutrophils detected by Western blotting for the serological diagnosis of primary sclerosing cholangitis. Hepatol. 1991, 14: 1147-1152. 10.1002\/hep.1840140632.","journal-title":"Hepatol"},{"key":"823_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0168-8278(05)80056-X","volume":"20","author":"R Klein","year":"1994","unstructured":"Klein R, Huizenga JR, Gips CH, Berg PA: Antimitochondrial antibody profiles in patients with primary biliary cirrhosis before orthotopic liver transplantation and titres of antimitochondrial antibody-subtypes after transplantation. J Hepatol. 1994, 20: 181-189. 10.1016\/S0168-8278(05)80056-X.","journal-title":"J Hepatol"},{"key":"823_CR18","first-page":"295","volume":"9","author":"NV Bergasa","year":"1996","unstructured":"Bergasa NV, Jones A, Kleiner D, Rabin L, Park Y, Wells MC, Hoofnagle JH: Pilot study of low dose oral methotrexate treatment for primary biliary cirrhosis. Am J Gastroenterol. 1996, 9: 295-299.","journal-title":"Am J Gastroenterol"},{"key":"823_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0168-8278(05)80004-2","volume":"18","author":"HP Buscher","year":"1993","unstructured":"Buscher HP, Zietzschmann Y, Gerok W: Positive response to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone. J Hepatol. 1993, 18: 9-14. 10.1016\/S0168-8278(05)80004-2.","journal-title":"J Hepatol"},{"key":"823_CR20","first-page":"757","volume":"268","author":"MM Kaplan","year":"1989","unstructured":"Kaplan MM: Methotrexate treatment of chronic cholestatic liver disease: friend or foe. Quart J Med. 1989, 268: 757-761.","journal-title":"Quart J Med"},{"key":"823_CR21","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/0016-5085(91)90085-Y","volume":"101","author":"MM Kaplan","year":"1991","unstructured":"Kaplan MM, Knox TA: Treatment of primary biliary cirrhosis with low-dose weekly methotrexate. Gastroenterol. 1991, 101: 1332-1338.","journal-title":"Gastroenterol"},{"key":"823_CR22","doi-asserted-by":"publisher","first-page":"429","DOI":"10.7326\/0003-4819-109-5-429","volume":"109","author":"MM Kaplan","year":"1998","unstructured":"Kaplan MM, Knox TZ, Arora S: Primary biliary cirrhosis treated with low-dose oral pulse methotrexate. Ann Intern Med. 1998, 109: 429-431.","journal-title":"Ann Intern Med"},{"key":"823_CR23","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1002\/hep.20897","volume":"42","author":"B Combes","year":"2005","unstructured":"Combes B, Emerson SS, Flye NL, Munoz SJ, Luketic VA, Mayo MJ, McCashland TM, Zetterman RK, Peters MG, Di Bisceglie AM, et al: Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis. Hepatol. 2005, 42: 1184-1193. 10.1002\/hep.20897.","journal-title":"Hepatol"},{"key":"823_CR24","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.cgh.2011.05.010","volume":"9","author":"J Leung","year":"2011","unstructured":"Leung J, Bonis PA, Kaplan MM: Colchicine or methotrexate, with ursodiol, are effective after 20 years in a subset of patients with primary biliary cirrhosis. Clin Gastroenterol Hepatol. 2011, 9: 776-780. 10.1016\/j.cgh.2011.05.010.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"823_CR25","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1055\/s-2005-916321","volume":"25","author":"P Invernizzi","year":"2005","unstructured":"Invernizzi P, Selmi C, Ranftler C, Podda M, Wesierska-Gadek J: Antinuclear antibodies in primary biliary cirrhosis. Semin Liver Dis. 2005, 25: 298-310. 10.1055\/s-2005-916321.","journal-title":"Semin Liver Dis"},{"key":"823_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1084\/jem.180.1.273","volume":"180","author":"B Das","year":"1994","unstructured":"Das B, Mondragon MO, Sadeghian M, Hatcher VB, Norin AJ: A novel ligand in lymphocyte -mediated cytotoxicity: expression of the beta subunit of h + transporting ATP synthase on the surface of tumor cell lines. J Exp Med. 1994, 180: 273-281. 10.1084\/jem.180.1.273.","journal-title":"J Exp Med"},{"key":"823_CR27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10863-010-9270-2","volume":"42","author":"V Giorgio","year":"2011","unstructured":"Giorgio V, Bisetto E, Franca R, Harris DA, Passamonti S, Lippe G: The ectopic f\/0)f(1) ATP synthase of rat liver is modulated in acute cholestasis by the inhibitor protein if1. J Bioenerg Biomembr. 2011, 42: 117-123.","journal-title":"J Bioenerg Biomembr"},{"key":"823_CR28","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/emm.2004.60","volume":"36","author":"BW Kim","year":"2004","unstructured":"Kim BW, Choo HJ, Lee JW, Kim JH, Ko YG: Extracellular ATP is generated by ATP synthase complex in adipocyte lipid rafts. Exp Mol Med. 2004, 36: 476-485.","journal-title":"Exp Mol Med"},{"key":"823_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nature01250","volume":"421","author":"LO Martinez","year":"2003","unstructured":"Martinez LO, Jacquet S, Esteve JP, Rollabd C, Cabezon E, Champagne E, Pineau T, Georgeaud V, Walker JE, Terce F, et al: Ectopic beta-chain of ATP synthase is an apolipoprotein a-i receptor in hepatic HDL endocytosis. Nature. 2003, 421: 75-79. 10.1038\/nature01250.","journal-title":"Nature"},{"key":"823_CR30","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1073\/pnas.96.6.2811","volume":"96","author":"TL Moser","year":"1999","unstructured":"Moser TL, Stack MS, Asplin I, Enghild JJ, Hojrup P, Everitt L, Hubchak S, Schnaper HW, Pizzo SV: Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc Natl Acad Sci USA. 1999, 96: 2811-2816. 10.1073\/pnas.96.6.2811.","journal-title":"Proc Natl Acad Sci USA"},{"key":"823_CR31","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1161\/ATVBAHA.109.187997","volume":"29","author":"C Radojkovic","year":"2009","unstructured":"Radojkovic C, Genoux A, Pons V, Combes G, de Jonge H: Stimulation of cell surface f1-ATPase activity by apolipoprotein a-i inhibits endothelial cell apoptosis and promotes proliferation. Arterioscler Thromb Vasc Biol. 2009, 29: 1125-1130. 10.1161\/ATVBAHA.109.187997.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"823_CR32","doi-asserted-by":"publisher","first-page":"6656","DOI":"10.1073\/pnas.131067798","volume":"98","author":"TL Moser","year":"2001","unstructured":"Moser TL, Kenan DJ, Ashley TA, Roy JA, Goodman MD, Misra UK, Cheek DJ, Pizzo SV: Endothelial cell surface f1-f0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin. Proc Natl Acad Sci USA. 2001, 98: 6656-6661. 10.1073\/pnas.131067798.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-12-152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-12-152\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-12-152","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-12-152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T18:02:44Z","timestamp":1714500164000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-12-152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,24]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["823"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-12-152","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,24]]},"assertion":[{"value":"12 June 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"152"}}